CLEARLLAB REAGENTS
Mexico·Clase I·III. DIAGNOSTIC AGENTS·BECKMAN COULTER DE MÉXICO, S.A. DE C.V.·Registered April 22, 2019LOS REACTIVOS CLEARLLAB ESTÁN CONCEBIDOS PARA USO DIAGNÓSTICO IN VITRO COMO UN PANEL DE DETECCIÓN PARA LA IDENTIFICACIÓN DE DISTINTAS POBLACIONES CELULARES MEDIANTE INMUNOFENOTIPADO EN UN CITÓMETRO DE FLUJO FC 500
CLEARLLAB REAGENTS ARE DESIGNED FOR IN VITRO DIAGNOSTIC USE AS A DETECTION PANEL FOR THE IDENTIFICATION OF DIFFERENT CELL POPULATIONS BY IMMUNOPHENOTYPING ON AN FC 500 FLOW CYTOMETER
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PANEL PARA DETECTAR POBLACIONES CELULARES
- Trade Name (English)
- PANEL TO DETECT CELL POPULATIONS
- Analysis ID
- 820R2019 SSA
- Registration Date
- April 22, 2019
- Name (Spanish)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
- Name (English)
- BECKMAN COULTER DE MÉXICO, S.A. DE C.V.
Access comprehensive regulatory information for CLEARLLAB REAGENTS (CLEARLLAB REAGENTS) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 820R2019 SSA and manufactured by BECKMAN COULTER DE MÉXICO, S.A. DE C.V.. The device was registered on April 22, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.